Press

Maiwald in the press

Press Coverage

Royalty Pharma and Cytokinetics Announce Expanded Strategic Funding Collaboration Totaling up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline

Deal provides Cytokinetics with diversified access to capital as company advances its specialty cardiology franchise NEW YORK, NY and SOUTH SAN FRANCISCO, CA, May 22, 2024 – Royalty Phar...

Continue reading

Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab

Frexalimab is in Phase 3 development by Sanofi in multiple sclerosis with multi-blockbuster potential in a wide range of immune-mediated diseases Expands Royalty Pharma’s ...

Continue reading

The UPC has become known for its expeditious decision-making processes

The UPC has become known for its expeditious decision-making processes. Just how expeditious it can be, has been shown in a recent case filed with the Munich local division against one of our clients. After a quick review of the claimant’s statement of claim, we infor...

Continue reading

All press coverage

Maiwald press releases

Another success for Maiwald and betapharm Arzneimittel GmbH

We are happy to report that the oppositions filed by our client betapharm and eight other generics manufacturers against Novartis patent EP 3 351 246 were successful; the Board of Appeal of the European Patent Office revoked the Novartis patent for lack of inventive step (fi...

Continue reading

Maiwald wins important opposition case for its client Acetate International LLC at the European Patent Office

Maiwald GmbH in Munich has achieved an important victory for its client Acetate International LLC at the European Patent Office. Acetate International LLC is part of the Celanese group which has a long history of producing cellulose acetate products for commercial applicatio...

Continue reading

Law firm will in future operate as Maiwald GmbH

Munich, 11 October 2022 - Maiwald, one of Germany's largest and most renowned law firms in the field of intellectual property, will in future operate under a new name: Effective October 11, 2022, Maiwald Patentanwaltsgesellschaft und Rechtsanwaltsgesellschaft mbH changed its...

Continue reading

All press releases

Press Contact

Dr. Eva Dörner

Partner

German Patent Attorney

European Patent Attorney

UPC Representative

Chemist